Amino Acid Ester Prodrugs of the Antiviral Agent 2-Bromo-5,6-dichloro-1-(β-<scp>d</scp>-ribofuranosyl)benzimidazole as Potential Substrates of hPEPT1 Transporter

Hayden, F. G. Antiviral agents.Goodman & Gilman's The PharmacologicalBasis of Therapeutics,10th ed.; McGraw-Hill:  New York, 2001; pp 1313−1347.

De Clercq E., 2001, J. Clin. Virol., 22, 89, 10.1016/S1386-6532(01)00167-6

Kennedy T, 1997, Drug Discuss. Today, 2, 444, 10.1016/S1359-6446(97)01099-4

Thummel, K. E.; Shen, D. A. Design and Optimization of Dosage Regimens:  Pharmacokinetic Data.Goodman & Gilman's The Pharmacological Basisof Therapeutics,10th ed.; McGraw-Hill:  New York, 2001; pp 1917−2023.

Fleisher D., 1996, Adv. Drug Delivery Rev., 19, 130, 10.1016/0169-409X(95)00103-E

Han H. K., 2000, AAPS Pharmsci., 2, E6

Oh, D. M.; Han, H. K.; Amidon, G. L. Drug Transport and Targeting. Intestinal Transport.Membrane Transporters as Drug Targets; Kluwer Academic/Plenum:  New York, 1999; pp 59−88.

Balimane P. V., 1998, Biochem. Biophys. Res. Commun., 250, 251, 10.1006/bbrc.1998.9298

Han H., 1998, Pharm. Res., 15, 1159

Sugawara M., 2000, J. Pharm. Sci., 89, 789, 10.1002/(SICI)1520-6017(200006)89:6<781::AID-JPS10>3.0.CO;2-7

Shin H.-C., 2003, Drug Bioavailability/Estimation of Solubility, Permeability and Absorption

Rubio-Aliaga I., 2002, Trends Pharmacol. Sci., 23, 440, 10.1016/S0165-6147(02)02072-2

Nielsen C. U., 2002, Exp. Opin. Ther. Pat., 12, 1350, 10.1517/13543776.12.9.1329

Inui K., 1999, Pharm. Biotechnol., 12, 288

Meredith D., 2000, Cell Mol. Life Sci., 57, 778, 10.1007/s000180050040

Herrera-Ruiz D., 2003, J. Pharm. Sci., 92, 714, 10.1002/jps.10303

Meier C., 1998, Synth. Lett., 233, 242

Wagner C. R., 2000, Med. Res. Rev., 20, 451, 10.1002/1098-1128(200011)20:6<417::AID-MED1>3.0.CO;2-Z

Tobias D. C., 2004, Mol. Pharm., 2, 116

Townsend L. B., 1995, J. Med. Chem., 38, 4105, 10.1021/jm00020a025

Zou R., 1997, J. Med. Chem., 40, 818

Underwood M. R., 1998, J. Virol., 72, 725, 10.1128/JVI.72.1.717-725.1998

Good S. S., 1994, 7th International Conference on Antiviral Research

Chulay J., 1999, Adv. Exp. Med. Biol., 458, 134

Lalezari J. P., 2002, Antimicrob. Chemotherap., 46, 2976

Vig B. S., 2003, American Association of Pharmaceutical Scientists Annual Meeting & Exposition

Faria T. N., 2003, Mol. Pharm., 1, 76, 10.52494/TQWM8592

Tateoka R., 2001, Bioconjugate Chem., 12, 492, 10.1021/bc000135u

Tamura K., 1996, Pharm. Res., 13, 1667

Tamura K., 1996, Pharm. Res., 13, 1213, 10.1023/A:1016068421243

Sun D., 2001, AAPS PharmSci., 3, E2

Hsu C. P., 1998, Pharm. Res., 15, 1381